Therapeuticsmd(Txmd) Financials: Inventory Turnover Compared To Industry Average, Plus Other Key Ratios

Report Profitability Growth Liquidity Solvency Valuation

fixed asset turnover inventory turnover payables turnover receivables turnover total asset turnover working capital turnover

Growth Trend (Last 5 Years)

Growth - inventory turnover

This chart shows the historical trend of inventory turnover for TXMD compared to its industry average over the recent years.

Ratio Definition and Interpretation

Name: Inventory Turnover

Definition: Inventory turnover measures how quickly the company sells and replaces its inventory. A higher turnover means products are selling fast and inventory isn’t sitting idle. Slow turnover may suggest weak sales, poor demand forecasting, or obsolete inventory piling up — all of which can tie up cash unnecessarily.

Interpretation:
• In '2020', TXMD's inventory turnover was 2.00, reflecting efficiency in managing inventory stock. Industry average for Biotechnology: Pharmaceutical Preparations in '2020' stood at 1.56.
• In '2021', TXMD's inventory turnover was 0.18, reflecting efficiency in managing inventory stock. The decline from '2020' may indicate some operational or financial challenges. Industry average for Biotechnology: Pharmaceutical Preparations in '2021' stood at 2.23. Industry average increased by 0.67 compared to previous year.
Overall, TXMD's inventory turnover has been volatile but showed a downward trend over the past 2 years.

Formula: Inventory Turnover = Cost of Goods Sold / Average Inventory

Good Range: Typically 4 to 12 depending on industry.